Research frontiers inc (REFR)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Fee income

356

-

462

-

418

-

359

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fee income

-

-

-

301

-

370

-

324

433

279

488

348

393

277

304

244

409

378

445

803

379

441

452

395

308

-

506

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses

820

1,320

666

939

751

814

572

645

1,009

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fee income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

521

707

552

471

450

482

353

207

140

144

137

161

Operating expenses

-

-

-

-

-

-

-

-

-

-

607

636

1,136

-

624

865

1,186

1,712

895

961

1,172

1,414

778

1,196

1,037

2,448

1,002

918

1,667

837

972

852

1,439

877

678

736

1,325

585

590

Research and development

183

284

207

313

229

203

190

250

218

201

185

202

211

257

246

503

410

492

327

334

434

498

324

349

449

747

424

394

636

433

369

391

477

310

340

327

411

305

297

Total expenses

1,003

1,655

873

1,253

981

1,018

763

896

1,228

948

792

838

1,347

1,667

870

1,369

1,596

2,204

1,222

1,296

1,606

1,912

1,102

1,546

1,486

3,196

1,427

1,312

2,304

1,270

1,341

1,243

1,917

1,188

1,019

1,063

1,737

891

888

Operating loss

-647

-1,274

-410

-952

-562

-647

-403

-571

-795

-669

-304

-490

-954

-1,389

-566

-1,124

-1,187

-1,826

-776

-492

-1,227

-1,470

-649

-1,150

-1,178

-2,770

-920

-790

-1,597

-718

-869

-793

-1,434

-834

-812

-923

-1,593

-753

-727

Warrant market adjustment

-

0

0

404

247

8

286

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net investment income

22

17

13

6

6

4

2

2

1

0

1

0

1

4

6

7

10

11

9

11

11

8

9

8

8

9

9

11

7

8

3

3

17

10

10

4

3

3

3

Loss before income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-710

-866

-789

-1,416

-823

-801

-919

-1,589

-

-

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-613

0

0

0

0

-

-

Net loss

-624

-1,256

-397

-1,350

-803

-634

-688

-569

-793

-668

-303

-489

-952

-1,385

-559

-1,116

-1,176

-1,814

-767

-481

-1,216

-1,462

-639

-1,141

-1,169

-2,760

-911

-779

-1,589

-710

-866

-789

-803

-823

-801

-919

-1,589

-749

-723

Basic and diluted net loss per common share

-0.02

-0.04

-0.01

-0.05

-0.03

-0.02

-0.03

-0.02

-0.03

-0.03

-0.01

-0.02

-0.04

-0.06

-0.02

-0.05

-0.05

-0.08

-0.03

-0.02

-0.05

-0.06

-0.03

-0.05

-0.05

-0.12

-0.04

-0.03

-0.07

-0.04

-0.04

-0.04

-0.04

-0.04

-0.04

-0.05

-0.09

-0.04

-0.04

Weighted average number of common shares outstanding

31,323

31,169

31,065

29,589

28,221

27,697

26,002

25,432

24,691

24,043

24,043

24,043

24,043

24,043

24,043

24,043

24,043

24,085

23,996

24,005

23,944

24,056

23,924

23,554

23,117

23,035

22,916

22,916

22,916

-

20,013

18,907

-

-

-

-

-

-

-

Basic and diluted weighted average number of common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,907

-

18,544

18,544

18,518

17,062

17,151